BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CEACAM5, CEA AND Prognosis
8 results:

  • 1. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse prognosis.
    Yu S; Zhao H; Meng H; Shi S; Cao S; Bian T; Ruan C
    Genet Res (Camb); 2023; 2023():8586507. PubMed ID: 37113556
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Prognostic Value of the Expression of Myeloid leukemia Factor 1-Interacting Protein in Gastric Cancer and Its Regulatory Role in Tumor Progression].
    Yang Z; Zhang H; Xu MY; Zhang XF; Wang YY; Ge ST; Geng ZJ; Song X; Li J; Hu JG; Zuo LG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):114-121. PubMed ID: 36647653
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of hub genes associated with adult acute myeloid leukemia progression through weighted gene co-expression network analysis.
    Zhu R; Lin W; Tang L; Hu Y
    Aging (Albany NY); 2021 Feb; 13(4):5686-5697. PubMed ID: 33592582
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer.
    Jiang W; Bai W; Li J; Liu J; Zhao K; Ren L
    Int J Cancer; 2021 Feb; 148(4):1006-1013. PubMed ID: 32914874
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Level of N6-Methyladenosine in Peripheral Blood RNA: A Novel Predictive Biomarker for Gastric Cancer.
    Ge L; Zhang N; Chen Z; Song J; Wu Y; Li Z; Chen F; Wu J; Li D; Li J; Wang C; Wang H; Wang J
    Clin Chem; 2020 Feb; 66(2):342-351. PubMed ID: 32040577
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.
    Uehara K; Ikehara F; Tanabe Y; Nakazato I; Oshiro M; Inamine M; Kinjo T
    Diagn Pathol; 2016 Feb; 11():16. PubMed ID: 26830028
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Carcinoembryonic antigen-specific but not antiviral CD4+ T cell immunity is impaired in pancreatic carcinoma patients.
    Tassi E; Gavazzi F; Albarello L; Senyukov V; Longhi R; Dellabona P; Doglioni C; Braga M; Di Carlo V; Protti MP
    J Immunol; 2008 Nov; 181(9):6595-603. PubMed ID: 18941250
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Current status of carcinoembryonic antigen assay.
    Chu TM
    Semin Nucl Med; 1975 Jul; 5(3):255-62. PubMed ID: 1154032
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.